OM Pharma is a Swiss-based biopharmaceutical company operating globally. It is a leader in the treatment of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases. OM Pharma operates in 100 countries thanks to a strong network of international partners.
We develop bacterial-derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from infections and inflammation.
OM Pharma development pipeline also includes New Chemical Entities programs targeting immunological/neoplastic disorders (e.g. immuno-oncology, diabetic macular edema, pulmonary fibrotic disorders, macrophage-driven disorders).
We develop bacterial-derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from infections and inflammation.
OM Pharma development pipeline also includes New Chemical Entities programs targeting immunological/neoplastic disorders (e.g. immuno-oncology, diabetic macular edema, pulmonary fibrotic disorders, macrophage-driven disorders).
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
